| MSD (n = 660) | UD (n = 381) | p value |
---|---|---|---|
Engraftment | 606 (94.2%) | 359 (95.2%) | 0.5 |
Acute GVHD | Â | Â | 0.012 |
 Grade 0–I | 447 (72.1%) | 236 (64.5%) |  |
 Grade II–IV | 173 (27.9%) | 130 (35.5%) |  |
Outcome at 2Â years | |||
 Leukemia-free survival | 25.3% (21.6–28.9) | 28.3% (23.3–33.3) | 0.56 |
 Overall survival | 30.9% (27–34.9) | 34.3% (29–39.7) | 0.57 |
 Relapse | 53.7% (49.6–57.7) | 46.4% (40.9–51.7) | 0.04 |
 Non-relapse mortality | 21% (17.9–24.4) | 25.1% (21.7–28.6) | 0.11 |
Chronic GVHD | 28.9% (24.9–33) | 25.8% (20.8–31) | 0.77 |